Corneal transplantation is among the key means to revive sight to sufferers with corneal blindness
MIOK Keratoprosthesis has been permitted for itemizing by Nationwide Medical Merchandise Administration (NMPA), the Chinese language company for regulating medication and medical units. MIOK Keratoprosthesis is the world’s first ever permitted synthetic cornea that requires no co-implantation of donor corneas, and is of nice significance throughout the 60 million sufferers with corneal blindness worldwide, as MIOK Keratoprosthesis makes it not unattainable to revive sight to sufferers with corneal blindness, and ease the burden on their households.
Developed by Beijing Microkpro Medical Instrument, MIOK Keratoprosthesis is principally manufactured from clear PMMA plastic with wonderful optical properties and tissue tolerance, and it’s supposed to revive sight to sufferers with corneal blindness by offering a clear optical pathway by an opacified cornea within the handled eye.
MIOK Keratoprosthesis is indicated to sufferers with corneal blindness, in circumstances the place a corneal transplantation has failed or runs a excessive threat for failure, particularly to sufferers with corneal graft failures, corneal scarring/vascularization, chemical/thermal burns, autoimmune illnesses (Stevens-Johnson syndrome, pemphigoid, and many others.), symblepharon, and extreme dry eyes, and many others. Consequently, it’s an efficient remedy to sufferers with corneal blindness attributable to a variety of corneal accidents.